OTTAWA, ON – Following their Annual General Meeting, BioTalent Canada has broadened its leadership team with the announcement of 16 new and returning Board Members. Under the guidance of returning Chair, Reg… Read More
VICTORIA, BC — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, today announced the grant of… Read More
BURNABY, BC – Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunotherapy platform designed to restore innate immune function, is pleased to announce… Read More
NEW YORK & MAINZ, GERMANY — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the U.S. Food and Drug Administration (FDA)… Read More
Companies aim to support development of up to 15 new genomic medicine products Commercial licensing of lipid nanoparticle technology from Precision NanoSystems at foundation of deal SAN DIEGO, CA &… Read More
